Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers compared ITI-007 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared ITI-007, placebo and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 1, Open-label, Fixed-sequence, Cross-over Trial to Assess the Effects of a Single Dose of Prazosin or Propranolol in the Presence of Brexpiprazole/Sertraline at Steady-state on Blood Pressure
This study ended early.
In PrincetonThis study evaluated the safety of Centanafadine for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety of Centanafadine for people with ADHD.
This study has finished and is no longer accepting participants.
In HollywoodA Multiple-arm, Phase 1, Open-label Trial to Determine Dose Strength Equivalence and Effect of Food on To-Be-Marketed Centanafadine QD XR Capsules, Bioequivalence Between Clinical and To-Be-Marketed QD XR Capsules and Relative Bioavailability of To-Be-Marketed QD XR Capsules to SR Tablets in Healthy Adults
This study has finished and is no longer accepting participants.
Multiple locations, including Lenexa
An open trial of guided internet-delivered cognitive behavioural therapy education to determine the benefits of the UniWellbeing Course for consumers of Macquarie University Campus Wellbeing with symptoms of anxiety or low mood
This study was withdrawn before enrollment.
Location not clearly listed
An open trial of guided internet-delivered cognitive behavioural therapy education to determine the benefits of the Wellbeing Course for consumers of the Mental Health Association with symptoms of anxiety
This study has finished and is no longer accepting participants.
Location not clearly listedA Single-center, Open-label, 2-way Crossover Relative Bioavailability and Safety Trial With Two Differing Strength Tablets (3 x 5 mg vs. 1 x 15 mg) of Sublingually Administered Org 5222 in Subjects With Schizophrenia or Schizoaffective Disorder.
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In OrlandoResearchers studied Brexpiprazole, tracking side effects to assess safety and tolerability in people with bipolarity type I.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adult Subjects With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (Aripiprazole, Olanzapine, Quetiapine, or Risperidone)
This study has finished and is no longer accepting participants.
Multiple locations, including ChertseyWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.